Back to NVCR
VANGUARD GROUP INC NVCR Position History
NovoCure Limited • Healthcare
Quarters held
24
Latest value
$130.6M
Q4 2025
Peak value
$196M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $421K |
| Q1 2025 | $718K |
| Q1 2025 | $1.8M |
| Q1 2025 | $196 |
| Q1 2025 | $1.5M |
| Q1 2025 | $196M |
| Q2 2025 | $420K |
| Q2 2025 | $698K |
| Q2 2025 | $1.8M |
| Q2 2025 | $196 |
| Q2 2025 | $1.5M |
| Q2 2025 | $187M |
| Q3 2025 | $8.7M |
| Q3 2025 | $305K |
| Q3 2025 | $507K |
| Q3 2025 | $1.1M |
| Q3 2025 | $124.5M |
| Q3 2025 | $142 |
| Q4 2025 | $305K |
| Q4 2025 | $542K |
| Q4 2025 | $9.1M |
| Q4 2025 | $142 |
| Q4 2025 | $1.1M |
| Q4 2025 | $130.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $130.6M | 10.10M | — | — |
| Q4 2025 | $1.1M | 86.0K | — | — |
| Q4 2025 | $142 | 11 | — | — |
| Q4 2025 | $9.1M | 706.8K | — | — |
| Q4 2025 | $542K | 41.9K | — | — |
| Q4 2025 | $305K | 23.6K | — | — |
| Q3 2025 | $142 | 11 | — | — |
| Q3 2025 | $124.5M | 9.64M | — | — |
| Q3 2025 | $1.1M | 86.0K | — | — |
| Q3 2025 | $507K | 39.2K | — | — |
| Q3 2025 | $305K | 23.6K | — | — |
| Q3 2025 | $8.7M | 671.1K | — | — |
| Q2 2025 | $187M | 10.50M | — | — |
| Q2 2025 | $1.5M | 86.0K | — | — |
| Q2 2025 | $196 | 11 | — | — |
| Q2 2025 | $1.8M | 98.9K | — | — |
| Q2 2025 | $698K | 39.2K | — | — |
| Q2 2025 | $420K | 23.6K | — | — |
| Q1 2025 | $196M | 11.00M | — | — |
| Q1 2025 | $1.5M | 86.8K | — | — |
| Q1 2025 | $196 | 11 | — | — |
| Q1 2025 | $1.8M | 101.3K | — | — |
| Q1 2025 | $718K | 40.3K | — | — |
| Q1 2025 | $421K | 23.6K | — | — |
Other funds holding NVCR
$88.9M
$78.7M
$66M
$57.7M
$56.6M
$52.6M
$51.5M